| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ANKRD12_0010000 | Exon-Exon | chr18:9208655-9263886 | chr18:9208657-9263888 | 250 nt | 0.3120 |
| hsa_ANKRD12_0010700 | Exon-Exon | chr18:9208664-9221997 | chr18:9208666-9221999 | 630 nt | 0.4063 |
| hsa_ANKRD12_0010900 | Exon-Exon | chr18:9211582-9211782 | chr18:9211584-9211784 | 201 nt | 0.3731 |
| hsa_ANKRD12_0011000 | Exon-Exon | chr18:9211582-9216898 | chr18:9211584-9216900 | 344 nt | 0.3983 |
| hsa_ANKRD12_0011100 | Exon-Exon | chr18:9211582-9221997 | chr18:9211584-9221999 | 492 nt | 0.4045 |
| hsa_ANKRD12_0011400 | Intron-Exon-Intron | chr18:9211582-9239554 | chr18:9211584-9239556 | 250 nt | 0.2840 |
| hsa_ANKRD12_0011200 | Exon-Exon | chr18:9211582-9275665 | chr18:9211584-9275667 | 250 nt | 0.3200 |
| hsa_ANKRD12_0012300 | Exon-Exon | chr18:9221850-9221997 | chr18:9221852-9221999 | 148 nt | 0.4189 |
| hsa_ANKRD12_0012400 | Exon-Exon | chr18:9221850-9279642 | chr18:9221852-9279644 | 250 nt | 0.3200 |
| hsa_ANKRD12_0013400 | Exon-Exon | chr18:9254209-9275665 | chr18:9254211-9275667 | 250 nt | 0.3120 |
A study in humans demonstrated that circANKRD12 circANKRD12 was significantly upregulated in the peripheral blood of myocardial infarction patients compared to healthy controls, with RT-qPCR validation showing high diagnostic efficacy as reflected by an area under the curve of 0.7819 in receiver operating characteristic analysis [Li et al. DOI:10.3389/fcvm.2022.810257]. A study in humans demonstrated that the circANKRD12 was identified as a differentially expressed circular RNA in the peripheral blood of myocardial infarction patients and was confirmed in an AC16 cell model [Tian et al. DOI: 10.3390/molecules26041155].